annual CFF:
$515.26M+$63.73M(+14.11%)Summary
- As of today (June 17, 2025), GPCR annual cash flow from financing activities is $515.26 million, with the most recent change of +$63.73 million (+14.11%) on December 31, 2024.
- During the last 3 years, GPCR annual CFF has risen by +$412.01 million (+399.02%).
- GPCR annual CFF is now at all-time high.
Performance
GPCR Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$809.00K+$194.00K(+31.54%)Summary
- As of today (June 17, 2025), GPCR quarterly cash flow from financing activities is $809.00 thousand, with the most recent change of +$194.00 thousand (+31.54%) on March 31, 2025.
- Over the past year, GPCR quarterly CFF has increased by +$107.00 thousand (+15.24%).
- GPCR quarterly CFF is now -99.84% below its all-time high of $514.70 million, reached on June 30, 2024.
Performance
GPCR quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$515.37M+$107.00K(+0.02%)Summary
- As of today (June 17, 2025), GPCR TTM cash flow from financing activities is $515.37 million, with the most recent change of +$107.00 thousand (+0.02%) on March 31, 2025.
- Over the past year, GPCR TTM CFF has increased by +$232.86 million (+82.43%).
- GPCR TTM CFF is now -35.38% below its all-time high of $797.51 million, reached on June 30, 2024.
Performance
GPCR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GPCR Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.1% | +15.2% | +82.4% |
| 3 y3 years | +399.0% | +155.9% | +10000.0% |
| 5 y5 years | +1894.3% | - | - |
GPCR Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1675.9% | -99.8% | +206.9% | -35.4% | +1676.3% |
| 5 y | 5-year | at high | +1894.3% | -99.8% | +155.9% | -35.4% | >+9999.0% |
| alltime | all time | at high | +1894.3% | -99.8% | +155.9% | -35.4% | >+9999.0% |
GPCR Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $809.00K(+31.5%) | $515.37M(+0.0%) |
| Dec 2024 | $515.26M(+14.1%) | $615.00K(-181.2%) | $515.26M(-35.3%) |
| Sep 2024 | - | -$757.00K(-100.1%) | $796.28M(-0.2%) |
| Jun 2024 | - | $514.70M(>+9900.0%) | $797.51M(+182.3%) |
| Mar 2024 | - | $702.00K(-99.8%) | $282.51M(-37.4%) |
| Dec 2023 | $451.53M | $281.63M(>+9900.0%) | $451.53M(+166.3%) |
| Sep 2023 | - | $473.00K(-259.3%) | $169.59M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$297.00K(-100.2%) | $168.85M(-15.7%) |
| Mar 2023 | - | $169.73M(<-9900.0%) | $200.19M(+590.0%) |
| Dec 2022 | $29.01M(-71.9%) | -$316.00K(+22.0%) | $29.01M(-1.1%) |
| Sep 2022 | - | -$259.00K(-100.8%) | $29.33M(-0.9%) |
| Jun 2022 | - | $31.04M(-2243.4%) | $29.59M(-2143.4%) |
| Mar 2022 | - | -$1.45M | -$1.45M |
| Dec 2021 | $103.25M(+299.6%) | - | - |
| Dec 2020 | $25.84M | - | - |
FAQ
- What is Structure Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Structure Therapeutics?
- What is Structure Therapeutics annual CFF year-on-year change?
- What is Structure Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Structure Therapeutics?
- What is Structure Therapeutics quarterly CFF year-on-year change?
- What is Structure Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Structure Therapeutics?
- What is Structure Therapeutics TTM CFF year-on-year change?
What is Structure Therapeutics annual cash flow from financing activities?
The current annual CFF of GPCR is $515.26M
What is the all time high annual CFF for Structure Therapeutics?
Structure Therapeutics all-time high annual cash flow from financing activities is $515.26M
What is Structure Therapeutics annual CFF year-on-year change?
Over the past year, GPCR annual cash flow from financing activities has changed by +$63.73M (+14.11%)
What is Structure Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of GPCR is $809.00K
What is the all time high quarterly CFF for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash flow from financing activities is $514.70M
What is Structure Therapeutics quarterly CFF year-on-year change?
Over the past year, GPCR quarterly cash flow from financing activities has changed by +$107.00K (+15.24%)
What is Structure Therapeutics TTM cash flow from financing activities?
The current TTM CFF of GPCR is $515.37M
What is the all time high TTM CFF for Structure Therapeutics?
Structure Therapeutics all-time high TTM cash flow from financing activities is $797.51M
What is Structure Therapeutics TTM CFF year-on-year change?
Over the past year, GPCR TTM cash flow from financing activities has changed by +$232.86M (+82.43%)